adrenergic alpha-antagonists

Preferred Label : adrenergic alpha-antagonists;

MeSH definition : Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.;

MeSH synonym : alpha-adrenergic blockers; adrenergic alpha-receptor blockaders; alpha-antagonists, adrenergic; alpha adrenergic blockers; adrenergic alpha blockers; alpha-receptor blockaders, adrenergic; adrenergic alpha receptor blockaders; blocking agents, alpha-adrenergic; blockaders, adrenergic alpha-receptor; blockers, alpha-adrenergic; alpha-blockers, adrenergic; agents, alpha-adrenergic blocking; alpha blockers, adrenergic; alpha-adrenergic blocking agents; alpha adrenergic blocking agents; alpha-adrenergic receptor blockaders; blockaders, alpha-adrenergic receptor; adrenergic alpha-blockers; receptor blockaders, alpha-adrenergic; alpha adrenergic receptor blockaders; adrenergic alpha antagonists; alpha-Adrenergic Antagonists; Antagonists, alpha-Adrenergic; alpha Adrenergic Antagonists;

MeSH annotation : GEN or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-AGONISTS; DF: ADREN ALPHA ANTAG; general or unspecified; prefer specifics; do not confuse with ADRENERGIC ALPHA-AGONISTS;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000317;

UMLS CUI

C0001641;

ATC code(s)
- alpha and beta blocking agents [ATC Code]
- alpha and beta blocking agents and other diuretics [ATC Code]
- alpha and beta blocking agents and thiazides [ATC Code]
- alpha-adrenoreceptor antagonists [ATC Code]
- alpha-adrenoreceptor antagonists [ATC Code]
- alpha-adrenoreceptor antagonists and diuretics [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Alpha-adrenoreceptor antagonists [ICHI section]
CISMeF manual mappings
- Alpha adrenergic blocking drug [ICD-11 Extension code]
- Product containing alpha adrenergic receptor antagonist (product) [SNOMED CT concept]
- Substance with alpha adrenergic receptor antagonist mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Alpha-Adrenergic Antagonist [NCIt concept]
- Alpha-adrenoreceptor antagonists [Bloc CIM-11]
- alpha-adrenergic blocking agent, nos [SNOMED Notion]
- alpha-adrenoreceptor antagonists [ATC Code]
- alpha-adrenoreceptor antagonists [ATC Code]
Indexing information
- 1-(4-amino-6,7-dimethoxy-2--quinazolyl)-4-(4-(bis-2-chloroethylamino)benzoyl)piperazine [MeSH Supplementary Concept]
- buflomedil [MeSH Supplementary Concept]
- emakor [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptors, adrenergic, alpha [MeSH Descriptor]
Ne pas confondre avec
- adrenergic alpha-agonists [MeSH Descriptor]
Record concept(s)
- adrenergic alpha-Antagonists [MeSH concept]
SNOMED CT : is a
- indoramin [MeSH Descriptor]
- moxisylyte [MeSH Descriptor]
See also
- antihypertensive agents [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane [MeSH Supplementary Concept]
- 1,2,3,6-tetrahydro-1-(N-((4-(2-nitrophenyl)piperazin-1-yl)propyl)carboxamido)-4-methyl-6-(3,4-difluorophenyl)-2-oxopyrimidine [MeSH Supplementary Concept]
- 1-(2-pyrimidinyl)piperazine [MeSH Supplementary Concept]
- 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one [MeSH Supplementary Concept]
- 1-(N-(3-(4-methyl-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(3,4-difluorophenyl)-5-methoxycarbonyl-4-methoxymethyl-2-oxo-1,2,3,6-tetrahydropyrimidine [MeSH Supplementary Concept]
- 1-benzylimidazole [MeSH Supplementary Concept]
- 2-(beta-(3-iodo-4-hydroxyphenyl)ethylaminomethyl)tetralone [MeSH Supplementary Concept]
- 2-methoxyidazoxan [MeSH Supplementary Concept]
- 3-(4-(1-(4-fluorophenyl)-5-(1-methyl-1,2,4-triazol-3-yl)-1H-indol-3-yl)-1-piperidinyl)propionitrile [MeSH Supplementary Concept]
- 5-carboxamido-1-(N-(3-(4-cyano-4-phenylpiperidin-1-yl)propyl)carboxamido)-6-(2,4-difluorophenyl)-4-ethyl-2-oxo-1,2,3,6-tetrahydropyrimidine [MeSH Supplementary Concept]
- 5-methylurapidil [MeSH Supplementary Concept]
- 7,8-(methylenedioxy)-14-hydroxyberbane [MeSH Supplementary Concept]
- AR-C239 [MeSH Supplementary Concept]
- BE 2254 [MeSH Supplementary Concept]
- BMY 7378 [MeSH Supplementary Concept]
- BRL 44408 [MeSH Supplementary Concept]
- EEDQ [MeSH Supplementary Concept]
- L 657743 [MeSH Supplementary Concept]
- SK&F 104078 [MeSH Supplementary Concept]
- SNAP 6201 [MeSH Supplementary Concept]
- YM 12617 [MeSH Supplementary Concept]
- amosulalol [MeSH Supplementary Concept]
- arotinolol [MeSH Supplementary Concept]
- benalfocin [MeSH Supplementary Concept]
- benextramine [MeSH Supplementary Concept]
- benoxathian [MeSH Supplementary Concept]
- chlorethylclonidine [MeSH Supplementary Concept]
- dapiprazole [MeSH Supplementary Concept]
- dibenzylchlorethamine [MeSH Descriptor]
- dihydroergotoxine [MeSH Descriptor]
- efaroxan [MeSH Supplementary Concept]
- ergoloid mesylates [MeSH Descriptor]
- ifenprodil [MeSH Supplementary Concept]
- medroxalol [MeSH Supplementary Concept]
- mianserin [MeSH Descriptor]
- midaglizole [MeSH Supplementary Concept]
- monatepil [MeSH Supplementary Concept]
- moxisylyte [MeSH Descriptor]
- naftopidil [MeSH Supplementary Concept]
- nicergoline [MeSH Descriptor]
- nipradilol [MeSH Supplementary Concept]
- phenoxybenzamine [MeSH Descriptor]
- phentolamine [MeSH Descriptor]
- phenylpiperazine [MeSH Supplementary Concept]
- piperoxan [MeSH Descriptor]
- proroxan [MeSH Supplementary Concept]
- quinidine [MeSH Descriptor]
- tolazoline [MeSH Descriptor]
UMLS correspondences (same concept)
- Alpha adrenergic blocking drug [ICD-11 Extension code]
- Alpha-Adrenergic Antagonist [NCIt concept]
- Alpha-adrenoreceptor antagonists [Bloc CIM-11]
- Product containing alpha adrenergic receptor antagonist (product) [SNOMED CT concept]
- Substance with alpha adrenergic receptor antagonist mechanism of action (substance) [SNOMED CT concept]
- alpha-adrenergic blocking agent, nos [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients